Search Results - "Echeverria, Patricia"

A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV by Negredo, Eugènia, Jiménez, Montse, Puig, Jordi, Loste, Cora, Pérez-Álvarez, Núria, Urrea, Victor, Echeverría, Patricia, Bonjoch, Anna, Clotet, Bonaventura, Blanco, Julià, Winston, Alan

“…Objective Optimization of antiretroviral therapy and anti-inflammatory treatments, such as statins, are among the strategies aimed at reducing metabolic…”
Get full text

COVIDApp as an Innovative Strategy for the Management and Follow-Up of COVID-19 Cases in Long-Term Care Facilities in Catalonia: Implementation Study by Echeverría, Patricia, Mas Bergas, Miquel Angel, Puig, Jordi, Isnard, Mar, Massot, Mireia, Vedia, Cristina, Peiró, Ricardo, Ordorica, Yolanda, Pablo, Sara, Ulldemolins, María, Iruela, Mercé, Balart, Dolors, Ruiz, José María, Herms, Jordi, Clotet Sala, Bonaventura, Negredo, Eugenia

“…The coronavirus disease (COVID-19) pandemic has caused an unprecedented worldwide public health crisis that requires new management approaches. COVIDApp is a…”
Get full text

Empowering Patients Through Virtual Care Delivery: Qualitative Study With Micropractice Clinic Patients and Health Care Providers by Burton, Lindsay, Rush, Kathy L, Smith, Mindy A, Davis, Selena, Rodriguez Echeverria, Patricia, Suazo Hidalgo, Lina, Görges, Matthias

“…Prior to the wider adoption of digital health technologies during the COVID-19 pandemic, applications of virtual care were largely limited to specialist visits…”
Get full text

Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study by Echeverría, Patricia, Bonjoch, Anna, Puig, Jordi, Moltó, José, Paredes, Roger, Sirera, Guillem, Ornelas, Arelly, Pérez-Álvarez, Nuria, Clotet, Bonaventura, Negredo, Eugènia

“…Etravirine (ETR) was approved for patients with virological failure and antiretroviral resistance mutations. It has also shown antiviral efficacy in…”
Get full text

Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy by Negredo, Eugènia, Massanella, Marta, Puertas, Maria C, Buzón, Maria J, Puig, Jordi, Pérez-Alvárez, Núria, Pérez-Santiago, Josué, Bonjoch, Anna, Moltó, José, Jou, Antoni, Echeverría, Patricia, Llibre, Josep M, Martínez-Picado, Javier, Clotet, Bonaventura, Blanco, Julià

“…Immune hyperactivation in immunodiscordant patients can induce residual HIV replication and limit CD4 T cell recovery. We assessed the impact of raltegravir…”
Get full text

Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor–based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials by Borges, Álvaro H., Lundh, Andreas, Tendal, Britta, Bartlett, John A., Clumeck, Nathan, Costagliola, Dominique, Daar, Eric S., Echeverría, Patrícia, Gisslén, Magnus, Huedo-Medina, Tania B., Hughes, Michael D., Hullsiek, Katherine Huppler, Khabo, Paul, Komati, Stephanus, Kumar, Princy, Lockman, Shahin, MacArthur, Rodger D., Maggiolo, Franco, Matteelli, Alberto, Miro, Jose M., Oka, Shinichi, Petoumenos, Kathy, Puls, Rebekah L., Riddler, Sharon A., Sax, Paul E., Sierra-Madero, Juan, Torti, Carlo, Lundgren, Jens D.

“…Background. Previous studies suggest that nonnucleoside reverse-transcriptase inhibitors (NNRTIs) cause faster virologic suppression, while ritonavir-boosted…”
Get full text

Saquinavir/ritonavir monotherapy as a new nucleoside-sparing maintenance strategy in long-term virologically suppressed HIV-infected patients by Patricia, Echeverria, Domingo, Pere, Gutierrez, Mar, Gracia, Mateo, Fuster, Monse, Molto, José, Puig, Jordi, Perez-Alvarez, Nuria, Clotet, Bonaventura, Negredo, Eugenia

“…The high antiviral potency and low toxicity of saquinavir/ritonavir (SQV/r) prompted us to assess a viable strategy in chronic virologically suppressed…”
Get more information

High Prevalence of Sarcopenia in HIV-Infected Individuals by Negredo, Eugenia, Ornelas, Arelly, Estany, Carla, Puig, Jordi, Bonjoch, Anna, Echeverría, Patricia, Clotet, Bonaventura

“…Background. Sarcopenia is a geriatric syndrome that leads to a loss of functionality and mortality. Methods. We assessed the prevalence of sarcopenia in…”
Get full text

Immunoaging at Early Ages Could Drive a Higher Comorbidity Burden in People with HIV on Antiretroviral Therapy Compared with the Uninfected Population by Loste, Cora, Trigueros, Macedonia, Muñoz-López, Francisco, Urrea, Víctor, Martínez, Ana, González, Sandra, Puig, Jordi, Martín, Marta, Bonjoch, Anna, Echeverría, Patricia, Massanella, Marta, Negredo, Eugenia

“…This is an observational, cross-sectional, comparative case-control, pilot study aimed at assessing the impact of HIV infection and age on immunological…”
Get full text

Potential prescribing issues among older HIV‐infected subjects in a Mediterranean cohort: Does the current prevalence give cause for concern? by Loste, Cora, Moltó, José, Pérez‐Álvarez, Núria, Puig, Jordi, Echeverría, Patricia, Bonjoch, Anna, Fumaz, Carmina R., Lemos, Begoña, Estany, Carla, Clotet, Bonaventura, Negredo, Eugenia

“…Aims To determine the prevalence of potential prescribing issues (PPI) in HIV‐infected subjects aged ≥65 years according to the Beers and STOPP/START criteria…”
Get full text

Remote Health Monitoring in the Workplace for Early Detection of COVID-19 Cases during the COVID-19 Pandemic Using a Mobile Health Application: COVIDApp by Echeverría, Patricia, Puig, Jordi, Ruiz, José María, Herms, Jordi, Sarquella, Maria, Clotet, Bonaventura, Negredo, Eugenia

“…COVIDApp is a platform created for management of COVID-19 in the workplace. COVIDApp was designed and implemented for the follow-up of 253 workers from seven…”
Get full text

A Specific Mobile Health Application for Older HIV-Infected Patients: Usability and Patient's Satisfaction by Puig, Jordi, Echeverría, Patricia, Lluch, Teresa, Herms, Jordi, Estany, Carla, Bonjoch, Anna, Ornelas, Arelly, París, Deborah, Loste, Cora, Sarquella, Maria, Clotet, Bonaventura, Negredo, Eugènia

“…HIV infection is an increasingly complex chronic disease associated with numerous medical, psychological, and social problems. The life expectancy of affected…”
Get more information

Prevalence, progression, and management of advanced chronic kidney disease in a cohort of people living with HIV by Bonjoch, Anna, Juega, Javier, Echeverría, Patricia, Puig, Jordi, Perez‐Alvarez, Nuria, Bonal, Jordi, Loste, Cora, Clotet, Bonaventura, Negredo, Eugènia

“…Background Advanced kidney disease is an emerging problem in people living with HIV despite sustained viral suppression. Methods We performed a prospective…”
Get full text

Improvement in bone mineral density after switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: two-centre randomized pilot study (OsteoTDF study) by Negredo, Eugènia, Domingo, Pere, Pérez-Álvarez, Núria, Gutiérrez, Mar, Mateo, Gracia, Puig, Jordi, Escrig, Roser, Echeverría, Patricia, Bonjoch, Anna, Clotet, Bonaventura

“…Tenofovir has been associated with a decrease in bone mineral density (BMD). However, data on changes in BMD after discontinuing tenofovir are lacking. We…”
Get full text

Switching from a ritonavir-boosted PI to dolutegravir as an alternative strategy in virologically suppressed HIV-infected individuals by Negredo, Eugènia, Estrada, Vicente, Domingo, Pere, Gutiérrez, Maria Del Mar, Mateo, Gracia M, Puig, Jordi, Bonjoch, Anna, Ornelas, Arelly, Echeverría, Patricia, Estany, Carla, Toro, Jessica, Clotet, Bonaventura

“…Switching from PIs to dolutegravir in virologically suppressed HIV-infected individuals has not been assessed. The principal aim was to assess the evolution of…”
Get full text

Switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: changes in bone turnover markers and circulating sclerostin levels by Negredo, Eugènia, Diez-Pérez, Adolfo, Bonjoch, Anna, Domingo, Pere, Pérez-Álvarez, Núria, Gutierrez, Mar, Mateo, Gracia, Puig, Jordi, Echeverría, Patricia, Escrig, Roser, Clotet, Bonaventura

“…Tenofovir is involved in accelerated bone mineral density (BMD) loss. We recently published a hip BMD improvement at week 48 [+2.1% (95% CI: -0.6, 4.7) (P =…”
Get full text

Arterial oxygen saturation and heart rate after birth in newborns with and without maternal bonding by Bancalari, Aldo, Araneda, Heriberto, Echeverría, Patricia, Alvear, Marina, Romero, Luzmira

“…Background The aim of this study was to determine and compare changes in arterial oxygen saturation (SpO2) and heart rate (HR) in healthy term infants with and…”
Get full text

Pulse wave velocity as index of arterial stiffness in HIV-infected patients compared with a healthy population by Echeverría, Patricia, Bonjoch, Anna, Moltó, José, Jou, Antoni, Puig, Jordi, Ornelas, Arelly, Pérez-Álvarez, Nuria, Clotet, Bonaventura, Negredo, Eugenia

“…Chronic HIV infection leads to premature atherosclerosis. Arterial stiffness is considered a subclinical marker of cardiovascular disease. Pulse wave velocity…”
Get full text

High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy by Bonjoch, Anna, Echeverría, Patricia, Perez-Alvarez, Núria, Puig, Jordi, Estany, Carla, Clotet, Bonaventura, Negredo, Eugènia

“…► Scare data are available about the recovery of TDF-related renal toxicity. ► Evolution of renal parameters after tenofovir discontinuation was evaluated. ►…”
Get full text

High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs by Negredo, Eugènia, Langohr, Klaus, Bonjoch, Anna, Pérez-Alvárez, Núria, Estany, Carla, Puig, Jordi, Rosales, Joaquim, Echeverría, Patricia, Clotet, Bonaventura, Gómez, Guadalupe

“…Osteoporotic fractures still remain very infrequent and physicians rarely evaluate bone health. We wanted to assess the magnitude of this problem in the near…”
Get full text